Background Antifibrotic (AF) therapy has been shown to potentially reduce the risk of lung cancer (LC) in patients with ...

Protein tyrosine phosphatase non-receptor type 2 ( PTPN2 ) is a tyrosine phosphatase involved in T cell receptor signal ...

Introduction Evidence suggests that platelets play a significant role in inflammation in addition to their role in thrombosis. Systemic inflammation is linked to poor short and long term outcomes in ...

4 Members of the British Paediatric Respiratory Society Empyema Study Group: A Bush and M Rosenthal, Royal Brompton and Harefield NHS Trust, London; T Edmunds, Sick Children's NHS Trust Edinburgh; W ...

Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.) ...

Correspondence to Elisabeth Edvardsen, Department of Pulmonary Medicine, Oslo University Hospital, Ullevål, P.O. Box 4953 Nydalen, 0424 Oslo, Norway; elisabeth.edvardsen{at}nih.no Background Many ...

Correspondence to Dr Alison M DeDent, 513 Parnassus Ave, HSE 1314, Box 0111, University of California San Francisco, San Francisco, California CA 94143, USA; alison.dedent{at}ucsf.edu ...

Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease associated with significant systemic consequences. Recognition of the systemic manifestations has stimulated ...

Dr E Hnizdo, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS PB 163, Morgantown, WV 26505, USA BACKGROUND A study was undertaken to establish the chronic effect of ...

1 The James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, Vancouver, British Columbia, Canada 2 Department of Medicine (Pulmonary Division), University of British Columbia, Vancouver ...

Background: Interstitial lung disease (ILD) is characterised by exertional dyspnoea, exercise limitation and reduced quality of life. The role of exercise training in this diverse patient group is ...